论文部分内容阅读
目的着重于探讨胃溃疡患者运用埃索美拉唑和奥美拉唑三联疗法治疗的有效性与安全性。方法对80例本院2014年2月~2016年5月期间收治的胃溃疡患者进行研究,按照随机数字法分组,因而实验组与对照组各40例。对照组采用奥美拉唑三联疗法,实验组采用埃索美拉唑三联疗法,比较两组不良反应发生率与治疗总有效率。结果两组不良反应发生率无显著性差异(P>0.05);实验组治疗总有效率为95%,明显高于对照组,差异显著(P<0.05),具有统计学意义。结论埃索美拉唑三联疗法效果确切,胃溃疡患者无明显不良反应,临床应用价值极高。
Objective To investigate the efficacy and safety of triple therapy with esomeprazole and omeprazole in patients with gastric ulcer. Methods A total of 80 patients with gastric ulcer admitted from February 2014 to May 2016 in our hospital were studied according to random number method and divided into experimental group and control group with 40 cases in each group. In the control group, omeprazole triple therapy was used. In the experimental group, esomeprazole triple therapy was used to compare the incidence of adverse reactions and the total effective rate in both groups. Results There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). The total effective rate of the experimental group was 95%, which was significantly higher than that of the control group (P <0.05). Conclusion Esomeprazole triple therapy is effective and has no obvious adverse reactions in patients with gastric ulcer, and its clinical application value is very high.